Moez Elloumi

683 total citations
64 papers, 394 citations indexed

About

Moez Elloumi is a scholar working on Hematology, Genetics and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Moez Elloumi has authored 64 papers receiving a total of 394 indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Hematology, 19 papers in Genetics and 13 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Moez Elloumi's work include Chronic Myeloid Leukemia Treatments (22 papers), Chronic Lymphocytic Leukemia Research (13 papers) and Acute Lymphoblastic Leukemia research (11 papers). Moez Elloumi is often cited by papers focused on Chronic Myeloid Leukemia Treatments (22 papers), Chronic Lymphocytic Leukemia Research (13 papers) and Acute Lymphoblastic Leukemia research (11 papers). Moez Elloumi collaborates with scholars based in Tunisia, France and United States. Moez Elloumi's co-authors include Fattouma Makni, Inès Hadrich, Ali Ayadi, Stéphane Ranque, Saad Ali, Hatem Bellâaj, Abderrahim Khélif, Sourour Neji, Lobna Ben Mahmoud and Khaled Zeghal and has published in prestigious journals such as Blood, Clinica Chimica Acta and Journal of Medical Microbiology.

In The Last Decade

Moez Elloumi

56 papers receiving 389 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Moez Elloumi Tunisia 12 178 92 91 84 65 64 394
Eduard Schulz United States 10 145 0.8× 119 1.3× 54 0.6× 30 0.4× 94 1.4× 44 437
Joe N. Frost United Kingdom 11 184 1.0× 49 0.5× 110 1.2× 13 0.2× 37 0.6× 19 440
Ji Young Huh South Korea 11 64 0.4× 48 0.5× 48 0.5× 35 0.4× 21 0.3× 26 440
E. Patten United States 10 143 0.8× 21 0.2× 56 0.6× 20 0.2× 34 0.5× 19 313
Masafumi Seki Japan 12 59 0.3× 17 0.2× 44 0.5× 35 0.4× 45 0.7× 50 392
Sanne M. Meinderts Netherlands 6 95 0.5× 15 0.2× 73 0.8× 17 0.2× 47 0.7× 8 353
Eduard K. Petershofen Germany 12 327 1.8× 38 0.4× 93 1.0× 78 0.9× 26 0.4× 26 440
Thiago M. Steiner Australia 8 47 0.3× 24 0.3× 20 0.2× 26 0.3× 39 0.6× 11 440
Çağman Tan Türkiye 12 32 0.2× 35 0.4× 14 0.2× 42 0.5× 36 0.6× 47 340
Sharon Baum Israel 14 47 0.3× 30 0.3× 186 2.0× 90 1.1× 101 1.6× 58 567

Countries citing papers authored by Moez Elloumi

Since Specialization
Citations

This map shows the geographic impact of Moez Elloumi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Moez Elloumi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Moez Elloumi more than expected).

Fields of papers citing papers by Moez Elloumi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Moez Elloumi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Moez Elloumi. The network helps show where Moez Elloumi may publish in the future.

Co-authorship network of co-authors of Moez Elloumi

This figure shows the co-authorship network connecting the top 25 collaborators of Moez Elloumi. A scholar is included among the top collaborators of Moez Elloumi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Moez Elloumi. Moez Elloumi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Frikha, F., et al.. (2023). Biclonal Gammopathies in South Tunisia: Clinical and Biological Characteristics. Laboratory Medicine. 54(5). 464–468. 1 indexed citations
2.
Hmida, M. Ben, et al.. (2023). The presence of two light chain bands on immunofixation is associated with poor outcomes in newly diagnosed multiple myeloma patients. Annals of Hematology. 102(6). 1459–1466. 1 indexed citations
3.
Elloumi, Moez, et al.. (2023). Imatinib mesylate-induced acute hepatotoxicity. Journal of Oncology Pharmacy Practice. 29(8). 2027–2030. 2 indexed citations
4.
Kallel, Choumous, et al.. (2023). Patient Care Strategies for alloant-ibodies in Type 3 Von Willebrand Disease: A Southern Tunisia Perspective. Journal of Taibah University Medical Sciences. 18(6). S5–S5.
5.
Elloumi, Moez, et al.. (2021). Prospective observational study of palliative care in hematological malignancies: Report of one year of practice. Transfusion Clinique et Biologique. 29(1). 44–48. 1 indexed citations
6.
Mahmoud, Lobna Ben, H. Ghozzi, Ahmed Hakim, et al.. (2018). Use of MTHFR C677T polymorphism and plasma pharmacokinetics to predict methotrexate toxicity in patients with acute lymphoblastic leukemia. Advances in Clinical and Experimental Medicine. 27(8). 1061–1068. 20 indexed citations
7.
Aloulou, Hajer, et al.. (2017). Factor XIII deficiency in south of Tunisia. Blood Coagulation & Fibrinolysis. 28(6). 485–489. 1 indexed citations
8.
Mahmoud, Lobna Ben, H. Ghozzi, Ahmed Hakim, et al.. (2017). Oxidative Stress in Tunisian Patients With Acute Lymphoblastic Leukemia and Its Involvement in Leukemic Relapse. Journal of Pediatric Hematology/Oncology. 39(3). e124–e130. 11 indexed citations
9.
Kallel, Choumous, et al.. (2016). Hypodysfibrinogenemia: A novel abnormal fibrinogen associated with bleeding and thrombotic complications. Clinica Chimica Acta. 460. 55–62. 5 indexed citations
10.
Elloumi, Moez, et al.. (2012). Comprehensive analysis of BCR/ABL variants in chronic myeloid leukemia patients using multiplex RT-PCR.. PubMed. 58(5-6). 433–9. 16 indexed citations
11.
Elloumi, Moez, et al.. (2012). An unusual three-way translocation t(21;8;1)(q22;q22;q32) in a case of acute myeloid leukemia (M2). Annales de biologie clinique. 70(2). 213–216. 5 indexed citations
12.
Jedidi, Inès, et al.. (2012). Extra medullary hematopoiesis associated to congenital dyserythropoietic anemia II in adult. Annales de biologie clinique. 70(2). 217–220. 3 indexed citations
13.
Hadrich, Inès, Fattouma Makni, Sourour Neji, et al.. (2012). Amphotericin Bin vitroresistance is associated with fatalAspergillus flavusinfection. Medical Mycology. 50(8). 829–834. 48 indexed citations
14.
Jedidi, Inès, et al.. (2011). Acquired haemophilia B: a case report and literature review. Annales de biologie clinique. 69(6). 685–688. 5 indexed citations
15.
Youssef, Yosra Ben, Imed Harrabi, Balkis Meddeb, et al.. (2011). Molecular cytogenetic study of derivative chromosome 9 deletion in chronic myeloid leukemia patients. Medical Oncology. 29(2). 1151–1160. 2 indexed citations
16.
Bellâaj, Hatem, Héla Mnif, Saloua Makni, et al.. (2011). Plasmocytome ovarien bilatéral : une observation. Imagerie de la Femme. 21(3). 111–114. 2 indexed citations
17.
Hadrich, Inès, Charles Mary, Fattouma Makni, et al.. (2010). Comparison of PCR-ELISA and Real-Time PCR for invasive aspergillosis diagnosis in patients with hematological malignancies. Medical Mycology. 49(5). 1–6. 37 indexed citations
18.
Elloumi, Moez, et al.. (2009). Molecular cytogenetic characterization of variant Philadelphia translocations in chronic myeloid leukemia: genesis and deletion of derivative chromosome 9. Cancer Genetics and Cytogenetics. 194(1). 30–37. 21 indexed citations
19.
Mkaouar‐Rebai, Emna, et al.. (2009). Congenital factor XIII deficiency caused by two mutations in eight Tunisian families: molecular confirmation of a founder effect. Annals of Hematology. 89(5). 499–504. 21 indexed citations
20.
Elghezal, Hatem, Yosra Ben Youssef, Moez Elloumi, et al.. (2008). Cytogenetic analysis of 298 newly diagnosed cases of acute lymphoblastic leukaemia in Tunisia. Hematological Oncology. 26(2). 91–97. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eduard Schulz Breakdown of academic impact, for papers by Joe N. Frost Breakdown of academic impact, for papers by Ji Young Huh Breakdown of academic impact, for papers by E. Patten Breakdown of academic impact, for papers by Masafumi Seki Breakdown of academic impact, for papers by Sanne M. Meinderts Breakdown of academic impact, for papers by Eduard K. Petershofen Breakdown of academic impact, for papers by Thiago M. Steiner Breakdown of academic impact, for papers by Çağman Tan Breakdown of academic impact, for papers by Sharon Baum
Rankless by CCL
2026